Back to Ticker
Kwality Pharmaceuticals Limited
NSE: KPL₹3,366
-1.08%EOD · 19 OctMarket Cap
—
52W Range
₹3949 / ₹1561
Volume
29K
38.7% delivery
1Y Return
—
P/E Ratio
43.6
P/B Ratio
10.7
ROE
22.7%
Debt / Equity
39.62
Quality Score
Durability · Valuation · Momentum — objective math, not adviceC
45/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityGood · 60
ValuationPoor · 20
MomentumAverage · 50
High ROE (22.7%)
High debt load (D/E 39.6)
Technical Indicators
129d data — partial · objective math, not adviceReturns
1D
-1.1%
1W
-5.6%
1M
-3.0%
3M
+24.8%
6M
+105.0%
1Y
—
RSI (14)
35 Neutral
RS vs Nifty (3M)
+30.5pp
Moving Averages (price vs MA)
20-DMA
₹3577
below
50-DMA
₹3500
below
150-DMA
—
200-DMA
—
From 52W High
-14.8%
From 52W Low
+115.6%
Support (20D)
₹3227
Resistance (20D)
₹3840
Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.
News & FilingsGoogle News + BSE
KPL Stock Price and Chart — NSE:KPL
TradingView· 20 AprWe Think That There Are Issues Underlying Kwality Pharmaceuticals' (NSE:KPL) Earnings
Simply Wall Street· 27 MayKwality Pharmaceuticals KPL Share Price Update
Kalkine India· 21 AugKothari Sugars and Chemicals gets NSE no objection for merger with Kothari Petrochemicals
ChiniMandi· 20 AugTechnical Analysis of Kwality Pharmaceuticals Ltd (NSE:KPL)
TradingView· 11 MayKwality Pharmaceuticals (NSEI:KPL) - Stock Analysis
Simply Wall Street· 22 Apr
News via Google News · Not verified by IPOpulse · Not investment advice
Community discussion(0)
Sign in to join the discussion.
Sign inNo comments yet — be the first to share your view.